The company’s shares have fallen nearly 90 percent this year due to the growing popularity of GLP-1 drugs such as Ozempic and Wegovy.
Source link
The company’s shares have fallen nearly 90 percent this year due to the growing popularity of GLP-1 drugs such as Ozempic and Wegovy.
Source link
Lorem ipsum dolor sit amet, consectetur.
